Boston Scientific Corporation is a global developer, manufacturer, and marketer of medical devices used to diagnose and treat heart disease, peripheral vascular disease, gastrointestinal conditions, urological disorders, neurological conditions, and various cancers through minimally invasive and surgical approaches. The company sells its products to hospitals, physicians, and healthcare providers worldwide, which in turn bill third-party payers including government programs like Medicare and Medicaid as well as private insurance plans. Revenue is generated through device sales, with profitability influenced by reimbursement coverage and payment decisions by government and private payers, procedure volumes, competitive pricing pressures, and regulatory approval requirements across multiple jurisdictions.